endometriosis

The company has rededicated itself to a fully blood-based test pipeline, with its next assays focused on women's health, including endometriosis and ovarian, uterine, and cervical cancers.

The test is based on MDNA's Mitomic technology, which enables the isolation of mitochondrial DNA in circulation that may be used as biomarkers.

Scientists have identified patterns of gene expression that can diagnose endometriosis, using machine learning to analyze transcriptome data obtained from microarray testing of uterine tissue.

NEW YORK (GenomeWeb) – VolitionRx today announced a collaboration with the University of Oxford on a clinical study to develop biomarkers for the diagnosis of endometriosis using the firm's Nucleosomics platform.

NEW YORK (GenomeWeb News) – A Massachusetts-based team reporting in Science Translational Medicine has identified an abdominal fluid protein signature that's present in a subset of individuals with end

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Protagen today announced a collaboration with Bayer HealthCare Pharmaceuticals aimed at clinically validating diagnostic biomarkers for endometriosis.

Two research groups have identified genetic loci linked to polycystic ovary syndrome and endometriosis in individuals of Han Chinese and European descent, respectively.

The company will use the NIH grant to develop protein biomarkers for use in developing diagnostics for endometriosis.

Using its UNIarray protein array platform, the company plans to focus on the development of serum-based protein biomarker tests for the early detection of multiple sclerosis and the differential diagnosis of prostate cancer.

The company will explore the use of its UNIarray protein chip technology for the discovery of autoantibody patterns that are predictive of the disease.

Pages

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.